Clopidogrel-induced insulin autoimmune syndrome: A case report and analysis of clinical characteristics in Chinese patients.

J Int Med ResNov 3, 2026 (epub)

Haoyue Liu, Jing Wang, Yingying Wang et al.

✦ AI-curated · Sources linked

Case in brief

A 69-year-old Chinese man developed hypoglycemic symptoms and was diagnosed with insulin autoimmune syndrome after starting clopidogrel. His condition improved after clopidogrel was stopped and replaced with ticagrelor, alongside dietary modification and voglibose treatment. The report also reviewed published Chinese cases and compared their clinical characteristics with cases from other countries; the abstract does not provide further case-level diagnostic findings.

What made this case unusual

The report describes insulin autoimmune syndrome in association with clopidogrel, a drug-related adverse event that may be underrecognized when patients present with hypoglycemia.

Diagnostic / clinical pearl

In a patient with hypoglycemia, consider a medication-related cause; the report highlights clopidogrel-associated insulin autoimmune syndrome as a potential diagnostic consideration.

Source

Published in J Int Med Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.